ACP-105

Also known as: ACP105

Unknown

Classification

Sarm

Regulatory Status

not-established

Overview

ACP-105 is described as an orally studied selective androgen receptor modulator intended for tissue-selective anabolic signaling. Human clinical efficacy and safety are not established.

Evidence and limitations

Human/preclinical evidence breakdown is not available in this record.

Pathways

androgen-receptor-signalingselective androgen receptor modulatorandrogen receptor

Interactions & cautions

Drug interactions

androgens, anabolic steroids, or other SARMs — Potential additive androgen-pathway effects; no specific clinical interaction studies identified. (high)

These are observational flags for review, not individualized instructions.

Sources

https://www.fda.gov/consumers/consumer-updates/fda-warns-use-selective-androgen-receptor-modulators-sarms-among-teens-young-adults (opens in a new tab)
https://pubchem.ncbi.nlm.nih.gov/compound/ACP-105 (opens in a new tab)

Educational reference only — not medical advice.